A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
In the wake of the 2024 U.S. elections, stakeholders in the life sciences and health care industry are intensely focused on the policy ...
A tide change is rippling across healthcare. As industry leaders converged on San Francisco for the 2025 JP Morgan Healthcare conference, they echoed optimism about a renewed stability in healthcare, ...
Another year at the J.P. Morgan Healthcare Conference is in the books. | While major payers skipped out on this year’s event, ...
JPMorgan Chase named Curtis Reed on Tuesday as chief of the largest U.S. lender's government banking and healthcare, higher ...
These achievements, together with our stock performance over the last year, reflect investor confidence in our strategy and execution.” The Microcap Conference is the largest independent microcap ...
The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...
Jennifer Piepszak, Chief Operating Officer of JPMorgan Chase & Co., will present at the BofA Financial Services Conference at the 1 Hotel in Miami Beach, Florida on Tuesday, February 11, 2025 at 1:00 ...
Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ground floor.
Surgery centers are the next focus, President and CEO Martin Bonick told a recent industry conference. But that push is more ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...